S&P 500

5.277,51

0,80%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
Canadá
TSXV
Neovasc Inc. (NVC)
Neovasc Inc. (NVC) Notícias

NVC

Neovasc Inc. (NVC)

Neovasc Inc.

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSXV:NVC

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/06/2014	08:00	PR Newswire (Canada)	Neovasc Inc. Announces Receipt of Final Approval to Graduate to the TSX	TSXV:NVC	Neovasc Inc.
19/06/2014	08:00	PR Newswire (Canada)	Neovasc Inc. reports results of Annual General Meeting of Shareholders	TSXV:NVC	Neovasc Inc.
12/06/2014	15:18	PR Newswire (Canada)	Neovasc earns a spot in 2014 PROFIT 500 List	TSXV:NVC	Neovasc Inc.
06/06/2014	17:15	PR Newswire (Canada)	Neovasc Inc. provides initial comments on lawsuit	TSXV:NVC	Neovasc Inc.
22/05/2014	08:00	PR Newswire (Canada)	Neovasc Inc. reports financial results for first quarter 2014	TSXV:NVC	Neovasc Inc.
21/05/2014	11:45	PR Newswire (Canada)	Positive First-In-Human Experience With Neovasc's Tiara™ Transcatheter Mitral Valve Presented at EuroPCR 2014	TSXV:NVC	Neovasc Inc.
16/05/2014	08:00	PR Newswire (Canada)	Neovasc Inc. to begin trading on the NASDAQ Capital Market	TSXV:NVC	Neovasc Inc.
13/05/2014	08:00	PR Newswire (Canada)	Neovasc Inc. Announces Upcoming Presentations at EuroPCR 2014	TSXV:NVC	Neovasc Inc.
08/05/2014	08:00	PR Newswire (Canada)	Neovasc Hires Industry Veteran Vicki Bebeau as Vice President, Clinical Affairs	TSXV:NVC	Neovasc Inc.
17/04/2014	19:17	PR Newswire (Canada)	Neovasc announces filing of shelf prospectus and application to list on NASDAQ	TSXV:NVC	Neovasc Inc.
17/04/2014	08:00	PR Newswire (Canada)	Neovasc Inc. Reports Financial Results For 2013	TSXV:NVC	Neovasc Inc.
31/03/2014	08:00	PR Newswire (Canada)	COSIRA Study Data Presented at ACC.14 Confirms the Neovasc Reducer(TM) Improves Functional Capabilities in Refractory Angina ...	TSXV:NVC	Neovasc Inc.
26/03/2014	10:24	Marketwired Canada	Neovasc Inc. Closes C$25 Million Bought Deal Equity Financing	TSXV:NVC	Neovasc Inc.
17/03/2014	08:00	PR Newswire (Canada)	Neovasc Reducer™ for Refractory Angina Featured in Live Case Session at 10th Annual Congress of Update in Cardiology and Ca...	TSXV:NVC	Neovasc Inc.
04/03/2014	09:00	PR Newswire (Canada)	Neovasc Inc. Provides Update on Tiara™ Transcatheter Mitral Valve and Reducer™ Programs	TSXV:NVC	Neovasc Inc.
03/03/2014	17:42	Marketwired Canada	Neovasc Announces C$25,152,000 Bought Deal Equity Financing	TSXV:NVC	Neovasc Inc.
03/02/2014	10:15	PR Newswire (Canada)	Neovasc Inc. Announces Successful First Human Implant of Tiara™ Transcatheter Mitral Valve	TSXV:NVC	Neovasc Inc.
20/11/2013	10:28	PR Newswire (Canada)	Neovasc Inc. Reports Financial Results for Third Quarter of 2013	TSXV:NVC	Neovasc Inc.
13/11/2013	10:28	PR Newswire (Canada)	Neovasc receives first US patent for its novel Tiara(TM) transcatheter mitral valve replacement technology	TSXV:NVC	Neovasc Inc.
06/11/2013	10:28	PR Newswire (Canada)	Neovasc Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients wit...	TSXV:NVC	Neovasc Inc.
29/10/2013	09:28	PR Newswire (Canada)	Neovasc Inc. Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular Interventions	TSXV:NVC	Neovasc Inc.
24/10/2013	09:28	PR Newswire (Canada)	Neovasc Inc. announces upcoming presentations at TCT 2013 scientific symposium	TSXV:NVC	Neovasc Inc.
15/08/2013	08:28	PR Newswire (Canada)	Neovasc Inc. reports financial results for second quarter of 2013	TSXV:NVC	Neovasc Inc.
28/05/2013	08:30	PR Newswire (Canada)	Neovasc Inc. Reports Financial Results for First Quarter of 2013	TSXV:NVC	Neovasc Inc.
23/05/2013	08:30	PR Newswire (Canada)	Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc's Tiara(TM) Transcatheter Mitral Valve into Human ...	TSXV:NVC	Neovasc Inc.
21/05/2013	08:30	PR Newswire (Canada)	Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer™ Improves Cardiovascular Parameters in Refractory Angi...	TSXV:NVC	Neovasc Inc.
13/05/2013	08:25	PR Newswire (Canada)	Neovasc Inc. Completes Enrollment in COSIRA Trial Assessing Efficacy of Reducer™ Product for Treatment of Refractory Angina	TSXV:NVC	Neovasc Inc.
29/04/2013	08:25	PR Newswire (Canada)	Neovasc Inc. reports financial results for 2012 year-end	TSXV:NVC	Neovasc Inc.
25/04/2013	08:30	PR Newswire (Canada)	Neovasc Inc. reports exercise of 1.8 million warrants for net proceeds of $2.3 million	TSXV:NVC	Neovasc Inc.
28/02/2013	09:30	PR Newswire (Canada)	Neovasc's COSIRA clinical trial protocol selected for publication in peer-reviewed journal	TSXV:NVC	Neovasc Inc.